292 related articles for article (PubMed ID: 30534126)
1. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
2. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
[TBL] [Abstract][Full Text] [Related]
3. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
4. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
[TBL] [Abstract][Full Text] [Related]
5. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
[TBL] [Abstract][Full Text] [Related]
6. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
[TBL] [Abstract][Full Text] [Related]
7. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice.
Song Q; Wang X; Wu X; Kang TH; Qin H; Zhao D; Jenq RR; van den Brink MRM; Riggs AD; Martin PJ; Chen YZ; Zeng D
Nat Commun; 2021 Feb; 12(1):805. PubMed ID: 33547295
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
[TBL] [Abstract][Full Text] [Related]
10. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
Front Immunol; 2020; 11():181. PubMed ID: 32117306
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
[TBL] [Abstract][Full Text] [Related]
13. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
Daenthanasanmak A; Iamsawat S; Chakraborty P; Nguyen HD; Bastian D; Liu C; Mehrotra S; Yu XZ
Blood; 2019 Jan; 133(3):266-279. PubMed ID: 30514750
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
15. G-CSF-Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way.
Perobelli SM; Mercadante AC; Galvani RG; Gonçalves-Silva T; Alves AP; Pereira-Neves A; Benchimol M; Nóbrega A; Bonomo A
J Immunol; 2016 Nov; 197(9):3725-3734. PubMed ID: 27707998
[TBL] [Abstract][Full Text] [Related]
16. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
17. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.
Lamarthée B; Malard F; Gamonet C; Bossard C; Couturier M; Renauld JC; Mohty M; Saas P; Gaugler B
Mucosal Immunol; 2016 Mar; 9(2):309-21. PubMed ID: 26153763
[TBL] [Abstract][Full Text] [Related]
18. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
[TBL] [Abstract][Full Text] [Related]
19. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
20. IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation.
Song Y; Hu B; Liu Y; Jin Z; Zhang Y; Lin D; Zhu Y; Lei L; Gong H; Mei Y; Teo HY; Wu D; Liu H
Eur J Immunol; 2018 Apr; 48(4):670-682. PubMed ID: 29282719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
